Description
Class A61P : THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
Subclass 3/06: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Antihyperlipidemics
A61P 3/06
Sub-Class
Stats
- 487 US PATENTS IN FORCE
- 119 US APPLICATIONS PENDING
- 121 Total Patent Owners
- 5,618 TOTAL INVENTORS
Recent Patents
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 11986464 | 5HT3R antagonist for use in treating aneurysms and cardiovascular risk | May 02, 22 | May 21, 24 | University of Kentucky Research Foundation |
| 11986530 | Drug composition for parenteral administration | Apr 27, 20 | May 21, 24 | THERABIOPHARMA INC.; Kyoto University; |
| 11986555 | Chewable pharmaceutical product for delivery of colesevelam hydrochloride | Feb 23, 22 | May 21, 24 | Cosette Pharmaceuticals, Inc. |
| 11981738 | ALK7 binding proteins and uses thereof | Oct 25, 18 | May 14, 24 | Acceleron Pharma Inc. |
| 11969456 | Lipoprotein complexes and manufacturing and uses thereof | Aug 04, 23 | Apr 30, 24 | ABIONYX PHARMA SA |
| 11970523 | Long-acting oxyntomodulin hybrid peptide, preparation method therefor, and application thereof | May 06, 19 | Apr 30, 24 | China Pharmaceutical University |
| 11963989 | Application of medical cell CMU-pb-7 in preparation of blood lipid-lowering drugs | Jun 17, 23 | Apr 23, 24 | GUANGDONG XINGHAI BIOTECHNOLOGY CO., LTD.; GUANGDONG XINGHAI INSTITUTE OF CELL; |
| 11965163 | HNF4a saRNA compositions and methods of use | Sep 28, 21 | Apr 23, 24 | MINA THERAPEUTICS LIMITED |
| 11957728 | Compositions for targeting receptor for advanced glycation end-products (RAGE) in a chronic inflammatory condition | Dec 16, 21 | Apr 16, 24 | SAMI-SABINSA GROUP LIMITED |
| 11944619 | Phenylalanine small organic compounds to directly modulate PCSK9 protein activity | Sep 14, 20 | Apr 02, 24 | SRX CARDIO, LLC |
| 11939343 | Sting agonist compounds and methods of use | Sep 09, 21 | Mar 26, 24 | MERSANA THERAPEUTICS, INC. |
| 11931348 | Methods of treating elevated plasma cholesterol | May 23, 22 | Mar 19, 24 | Montréal Heart Institute |
| 11925637 | Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use | Mar 30, 21 | Mar 12, 24 | SRX CARDIO, LLC |
| 11925660 | Treatment for obesity with superabsorbent materials | May 21, 21 | Mar 12, 24 | Not available |
| 11925674 | Methods for regulating free fatty acid flux using fat specific protein 27 (FSP27) compositions | Jul 26, 22 | Mar 12, 24 | Ohio University |
| 11926618 | Halogen-substituted phenylate compound and applications thereof | Aug 20, 20 | Mar 12, 24 | HINOVA PHARMACEUTICALS INC. |
| 11918602 | Methods for reducing cholesterol with superabsorbent materials | May 21, 21 | Mar 05, 24 | Not available |
| 11918620 | Traditional Chinese medicine composition, and preparation method therefor and application thereof | Jan 20, 21 | Mar 05, 24 | Suzhou Regen-PharmaTech Co., Ltd. |
| 11912718 | Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof | Aug 03, 21 | Feb 27, 24 | Gilead Apollo, LLC |
| 11903988 | Natural product compositions for management of cholesterol levels | Feb 11, 22 | Feb 20, 24 | Not available |
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2024/0175,035 | COMPOSITIONS AND METHODS FOR TREATING HYPERCHOLESTEROLEMIA | Mar 22, 22 | May 30, 24 | EmendoBio Inc. |
| 2024/0175,032 | COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF PCSK9 | Mar 07, 23 | May 30, 24 | Not available |
| 2024/0165,060 | METHOD AND COMPOSITION FOR LOWERING TOTAL SYSTEMIC CHOLESTROL, LDL CHOLESTEROL, AND NON-HDL CHOLESTEROL | Feb 02, 24 | May 23, 24 | Biokier, Inc. |
| 2024/0165,146 | Conjugated Antisense Compounds for Use in Therapy | Jun 23, 23 | May 23, 24 | Ionis Pharmaceuticals, Inc. |
| 2024/0165,093 | METHODS FOR TREATING FAMILIAL CHYLOMICRONEMIA SYNDROME | Mar 03, 22 | May 23, 24 | Not available |
| 2024/0156,785 | COMPOSITION FOR IMPROVING BLOOD CHOLESTEROL LEVEL | Mar 25, 22 | May 16, 24 | Suntory Holdings Limited |
| 2024/0156,826 | METHODS OF TREATING LIVER DISORDERS OR LIPID DISORDERS WITH A THR-BETA AGONIST | Sep 21, 23 | May 16, 24 | Not available |
| 2024/0156,987 | NUCLEIC ACID PRODUCTS AND METHODS OF ADMINISTRATION THEREOF | Jun 02, 23 | May 16, 24 | Not available |
| 2024/0148,683 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME | Aug 10, 23 | May 09, 24 | Not available |
| 2024/0122,956 | Application of Naringin Combined with Rapamycin in Preparation of Medications for Treating Hyperlipidemia | Dec 28, 23 | Apr 18, 24 | AIR FORCE MEDICAL UNIVERSITY |
| 2024/0123,027 | APOMERS | Jul 28, 23 | Apr 18, 24 | ABIONYX PHARMA SA |
| 2024/0115,502 | LIPOSOMES AND ITS USE FOR ENZYME DELIVERY | Jan 26, 22 | Apr 11, 24 | Not available |
| 2024/0115,661 | METHODS OF TREATING METABOLIC DISORDERS WITH FGF21 VARIANTS | Jul 26, 23 | Apr 11, 24 | Not available |
| 2024/0115,733 | COMPOSITIONS AND METHODS FOR TREATMENT OF NIEMANN PICK TYPE A DISEASE | Feb 01, 22 | Apr 11, 24 | Not available |
| 2024/0115,735 | MATERIALS AND METHODS FOR THE TREATMENT OF LYSOSOMAL ACID LIPASE DEFICIENCY (LAL-D) | Jan 26, 22 | Apr 11, 24 | Not available |
| 2024/0117,000 | GLUCAGON LIKE PEPTIDE 1 (GLP-1) FUSION PEPTIDE COUPLED CYCLIC PEPTIDE TYROSINE TYROSINE CONJUGATES AND USES THEREOF | Aug 31, 23 | Apr 11, 24 | Not available |
| 2024/0108,611 | COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES, CONTAINING TORSEMIDE AND CROMOLYN | Feb 07, 22 | Apr 04, 24 | ONCOCROSS CO. LTD. |
| 2024/0109,854 | BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS | Jun 02, 23 | Apr 04, 24 | Not available |
| 2024/0099,990 | CURCUMIN-BASED COMPOSITIONS & METHODS OF USE THEREOF | Dec 07, 23 | Mar 28, 24 | Not available |
| 2024/0101,692 | ANTI-APRIL ANTIBODIES AND USES THEREOF | Dec 29, 21 | Mar 28, 24 | Not available |
Top Owners in This Subclass
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 33 Months (last 2 years Issuances)
- 33 Months (last 5 years Issuances)